Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity-Reference-Cited by-同舟云学术

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity

Published:2017-04-06 Issue:8 Volume:19 Page:1135-1146
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Joannides Christos N.¹,Mangiafico Salvatore P.¹,Waters Matthew F.¹,Lamont Benjamin J.¹,Andrikopoulos Sofianos¹^ORCID

Affiliation:

1. Department of Medicine, Austin Hospital; University of Melbourne; Heidelberg Victoria Australia

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12923/fullpdf

Reference45 articles.

1. Mechanisms linking obesity to insulin resistance and type 2 diabetes;Kahn;Nature,2006

2. Investigational agents that protect pancreatic islet beta-cells from failure;Aston-Mourney;Expert Opin Investig Drugs,2005

3. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future;Kahn;Lancet,2014

4. A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society;Gunton;Med J Aust,2014

5. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial;Bailey;Lancet,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive Effects of SGLT-2 Inhibitors and Progress in Research;Advances in Clinical Medicine;2024

2. Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells;Frontiers in Pharmacology;2023-12-05

3. Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved;Clinical Nutrition;2023-12

4. Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study;Diabetes, Metabolic Syndrome and Obesity;2023-09

5. Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia;Cardiovascular Diabetology;2023-08-11